Polar Capital Holdings’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Polar Capital Holdings’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,351,113	Closed	-$83.6K	–	430
2022 Q3	$83.6K	Sell	1,351,113 -253,876	-16%	-$17.7M	0.53%	46
2022 Q2	$128K	Buy	1,604,989 +112,000	+8%	+$10.6M	0.75%	22
2022 Q1	$157K	Sell	1,492,989 -151,252	-9%	-$14.7M	0.71%	21
2021 Q4	$177K	Buy	1,644,241 +154,359	+10%	+$16.8M	0.66%	28
2021 Q3	$163K	Buy	1,489,882 +78,940	+6%	+$8.19M	0.67%	27
2021 Q2	$132K	Sell	1,410,942 -36,767	-3%	-$3.38M	0.57%	34
2021 Q1	$133M	Sell	1,447,709 -397,004	-22%	-$33.5M	0.82%	33
2020 Q4	$135M	Buy	+1,844,713	New	+$137M	0.82%	24

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Polar Capital Holdings's HZNP Position: Q4 2022 in Review

Polar Capital Holdings sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 1,351,113 shares — an estimated $83.6K sold.

Polar Capital Holdings first reported a position in HZNP in Q4 2020 and held it in 8 quarters. The position peaked at $135M in Q4 2020. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Polar Capital Holdings reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Polar Capital Holdings sold 1,351,113 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $83.6K.
Polar Capital Holdings first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 8 quarters.
Polar Capital Holdings's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $135M in Q4 2020.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Polar Capital Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.